Customer Service: 866-788-9007
×

SKIN
CANCER
CONNECT

November 2022

NOVEMBER 2022

DATA PRESENTED AT THE 42ND ANNUAL FALL CLINICAL DERMATOLOGY CONFERENCE®

The 42nd Annual Fall Clinical Dermatology Conference® took place from October 20-23 in Las Vegas, Nevada. New data from Castle's skin cancer tests was presented including new DecisionDx-Melanoma data from the NCI SEER program, new DecisionDx-SCC data from the prospective Clinical Utility and Health Outcomes Study (UTILISE), and a clinical impact study of MyPath Melanoma and DiffDx-Melanoma testing to guide surgical excisions and enhance management plan confidence. 

Optical Microscope is used for conducting planned, research experiments, educational demonstrations in medical and clinical laboratories. Close-up of scientist hands with microscope, examining samples and liquid. Photo of Young student scientist looking through a microscope in a laboratory. Young scientist doing some research.
iStock-1002000288
RESEARCH & DEVELOPMENT

One Test Helps Inform Two Key Clinical Decisions in the Management of Melanoma

Authored by Dr. Aaron Farberg, this article in Dermatology Times provides a comprehensive overview of current staging guidelines and DecisionDx-Melanoma testing, reviews a real-world case study, and shares impactful evidence supporting use of the test to guide patient management decisions.

 

Doctor talking to patient in office
RESEARCH & DEVELOPMENT

Poster Presentation Highlights Initial Data From DECIDE Study

The 19th International Congress of the Society for Melanoma Research (SMR) was held in Edinburgh, United Kingdom (Oct 17-20). At this meeting, Castle presented a poster which highlights the initial data from the DecisionDx-Melanoma Impact on Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes (DECIDE) study.

06CDO2021 image 1
CASE STUDY OF THE MONTH

Atypical Melanocytic Proliferation on Sensitive Preauricular Cheek

A 65-year-old male presents with an atypical melanocytic proliferation near the left ear. Four sites of basal cell carcinoma and seborrheic keratosis were taken at the same visit.

NOT REGISTERED?
NO PROBLEM!

Sign up for access to our monthly newsletter online
and directly in your inbox each month.

Scroll to Top
Scroll to Top